NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
FTIXX | Goldman Sachs Financial Square Treasury Instruments Fund Institutional Shares | null | null | 15.26% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.73% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 8.29% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.67% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.47% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.73% |
ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.11% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.92% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.87% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.28% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.25% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.14% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 2.03% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.03% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.83% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.75% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 1.71% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.68% |
ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.41% |
CI | Cigna Corp | Healthcare | Healthcare Plans | 1.37% |